A multicenter, randomized trial of posaconazole (POS) vs fluconazole (FLU) or itraconazole (ITZ) for prophylaxis of invasive fungal infections (IFIs) in neutropenic patients with acute myelogenous leukemia (AML) or myelodysplastic syndrome (MDS) receiving intensive chemotherapy
2006 ◽
Vol 12
(2)
◽
pp. 141
2008 ◽
Vol 28
(10)
◽
pp. 1223-1232
◽
2015 ◽
Vol 34
(11)
◽
pp. 1262-1264
◽